CytoSorbents Corporation

🌍 Meet us in Queenstown for ECMO Impossible 2024! 🌍 CytoSorbents is excited to join the global conversation on ECMO advancements at the ECMO Impossible 2024, happening from November 19th to 21st. Come discover cutting-edge innovations in extracorporeal life support. 🗓 Lunch Symposium 📅 Wednesday, November 20th, 2024 🕛 12:00 – 12:30 PM (NZ Time; GMT +12) Don’t miss our booth and the opportunity to connect with our team on the latest in critical care therapies! #CytoSorbents #ECMOImpossible2024 #CriticalCare #ExtracorporealSupport #QueenstownEvents #MedicalInnovation

Missed the live webinar? You can now watch the recording! 🎥 Topic: What’s new in the management of severe rhabdomyolysis? Join top specialists as they share key insights and the latest updates in the management of this critical condition: • Dr. Frederic Albrecht, Germany: Update on latest scientific data • Prof. Lui Forni, UK: Key messages of the International Consensus Report on hemoadsorption in rhabdomyolysis • Dr. Vedran Premuzič, Croatia: What are the consequences for the daily routine? Stay up to date with the latest in severe rhabdomyolysis management. 📲 Watch the recording here: https://lnkd.in/exKCv7pk

World Stroke Day - October 29, 2024 ❤️ One month after World Heart Day, we shift focus to stroke prevention and recovery. Strokes and cardiovascular health are closely linked, and taking steps to maintain a healthy heart and arteries can reduce your risk of stroke. At #CytoSorbents, we are committed to providing innovative solutions for critical care. On World Stroke Day, we stand with the global community to raise awareness about the importance of early detection, timely intervention, and recovery strategies for stroke victims. 💡 Did You Know? • High blood pressure is a leading risk factor for both heart disease and stroke. • Immediate medical attention during a stroke can save lives and minimize long-term effects. Join us in spreading awareness and empowering individuals to take control of their cardiovascular health. #WorldStrokeDay #StrokeAwareness #HeartHealth #CriticalCare

#DidYouKnow? In October 1907 Sir Thomas Lewis, one of the pioneers of ECG use in Cardiology, completed his Doctor of Medicine. Sir Thomas Lewis, born on December 26, 1881, in Wales, is one of the most influential figures in the early field of cardiology. His meticulous work with the first electrocardiograph (ECG) laid the foundation for many modern practices in cardiovascular medicine, making him an eminence in the understanding of heart rhythm disorders. By 1900, he had earned a Bachelor of Science degree from University College Cardiff and continued his medical studies at University College Hospital (UCH) in London, where he achieved his MBBS in 1905, earning a gold medal for his excellence. In 1907, Lewis obtained his Doctor of Medicine (M.D.), and his career took root at UCH, where he would spend the rest of his life. In 1908, Lewis introduced electrocardiography (ECG) to clinical practice, only a few years after the technology was pioneered by Willem Einthoven, with whom Lewis corresponded. His work on heart disease was not just groundbreaking; it was transformative, bringing the study of cardiac arrhythmias to the forefront of clinical research. In 1909, he co-founded the journal Heart with James MacKenzie, which he later renamed Clinical Science in 1933. He also founded the Medical Research Society in 1930, underscoring his dedication to fostering scientific inquiry and collaboration. Despite suffering a heart attack at the age of 45, Sir Thomas Lewis remained active in his field, though he gave up his habit of heavy smoking. Sadly, his life was cut short by coronary heart disease in 1945, yet his legacy lives on in the fields of cardiology and medical research. To learn more visit 👉 https://lnkd.in/eWdd8hb4 #Cardiology #MedicalHistory #MedicalPioneers #CardiovascularMedicine #Cytosorbents

Join Us in Queenstown, New Zealand! 🚨 We will be at EINZ 2024 from November 19-21! 🌏 Don't miss our Lunch Symposium on Wednesday, Nov 20th, from 12:00 – 12:30 PM (NZ Time, GMT+12) with Dr. Moritz Unglaube from Wiesbaden/Germany on "The Role of CytoSorb Hemoadsorption in ECMO Patients and Beyond: Advancing Critical Care". Mark your calendars now! 📅 #CytoSorbents #LunchSymposium

🌟 Medizin und Ökonomie im Fokus: Wie beeinflusst das Wirtschaftlichkeitsprinzip medizinische Entscheidungen in Kliniken? In unserem kommenden Webinar am 20. November 2024 (15:00 – 16:00 Uhr) erfahren Sie, welche Rolle die ökonomischen Aspekte bei der Bewertung des medizinischen Nutzens spielen und wie aktuelle gesundheitsökonomische Erkenntnisse den Klinikalltag prägen. Jetzt anmelden und mitdiskutieren! 🏥 👉 https://lnkd.in/eW2ifvRG #Medizincontrolling #CytoSorb #Webinar #Krankenhausmanagement EHLERS, EHLERS & PARTNER RECHTSANWALTSGESELLSCHAFT MBB

🆕 Webinar Tomorrow: October 23, 2024, 15:00 - 16:00 CET 🔔 Don’t miss this opportunity to stay up-to-date on the latest approaches to managing severe rhabdomyolysis. Join top specialists as they share insights: • Update on latest scientific data with Dr. Frederic Albrecht, Germany • Key messages of the International Consensus Report on hemoadsorption in rhabdomyolysis with Prof. Lui Forni, UK • What are the consequences for the daily routine? with Dr. Vedran Premuzič, Croatia ✅ Register now and secure your spot for tomorrow's webinar. https://lnkd.in/exKCv7pk #CytoSorbents #Rhabdomyolysis #Hemoadsorption

✨ Great News! ✨ https://lnkd.in/e6FJCXS6

CytoSorbents auf der Jahrestagung der DGfK und Fokustagung Herz 🔍 Besuchen Sie uns und erfahren Sie, wie die CytoSorb-Therapie helfen kann, bestimmte Herausforderungen in der Herzmedizin zu meistern. Nutzen Sie die Chance auf inspirierende Gespräche und praxisnahe Einblicke in innovative Therapien. 👉 https://cyto.news/DGfK2024 #DGfK2024 #Herzchirurgie #Intensivmedizin #CytoSorbents #MedTech #TatortHerzmedizin

Live from GICS 2024 – Day 1! We’re excited to kick off GICS 2024 here in Bengaluru, India! The event has officially begun, and it’s been an incredible day filled with insightful discussions and innovation in critical care. The inaugural ceremony set the tone for what promises to be an inspiring weekend. 🚨 Reminder for tomorrow! 🚨 Join us for an important session on hemoadsorption therapy: 🩺 Session: Personalizing Hemoadsorption in Critical Illness: Navigating Patient Complexity with CytoSorb Therapy 👨⚕️ Speaker: Dr. Yatin Mehta 🗣️ Moderator: Dr. Pradeep Rangappa 📅 Date: October 19, 2024 🕙 Time: 10:00 AM - 10:30 AM IST 📍 Venue: Hall B, Ocean Convention Center And don’t forget to stop by Booth G2 in partnership with Converge Biotech to explore our latest innovations and meet the CytoSorbents team! Stay tuned for more updates! #GICS2024 #CytoSorbents #CriticalCare #Hemoadsorption Converge Biotech